Stock Market Today, Feb. 18: ImmunityBio Soars After EU Approves ANKTIVA for Bladder Cancer
The Motley Fool
by newsfeedback@fool.com (Josh Kohn-Lindquist)February 18, 2026
On Feb. 18, 2026, investors weighed ImmunityBio’s EU bladder cancer win against its long slide since IPO and fresh legal scrutiny.
Verticals
financeinvesting
Originally published on The Motley Fool on 2/18/2026